Lindis Blood Care GmbH
PrivateLast Round
Follow-on Offering
Dec 12, 2024
Company Overview
Lindis Blood Care GmbH is a medical technology company developing CATUVAB®, a medical device designed to remove EpCAM-positive cancer cells from intraoperative blood to enable autologous blood transfusions during oncological surgeries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lindis Blood Care GmbH Comps
Public and private peers based on sector, stage, and business model.
Lindis Blood Care GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Dec 12, 2024 | ||||
| VC Round | Feb 9, 2022 | ||||
| Series A | Dec 13, 2019 |
Lindis Blood Care GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Series A |
| Brandenburg Kapital | Series A, VC Round, Follow-on Offering |
Lindis Blood Care GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lindis Blood Care GmbH's valuation, stock price, and market status.
